Cadila Healthcare Lupin

premium

It is unlikely for Zydus Cadila to repeat US feat this year, say analysts

Analysts doubt if other Indian firms in the segment will do much better in the formulations business in the US

Updated On: 19 Jul 2019 | 12:07 AM IST

premium

Cadila Healthcare with m-cap of Rs 54,719 cr, stood ahead of Lupin, which have m-cap of Rs 52,217 cr

Updated On: 08 Jun 2017 | 1:10 AM IST